Industry Educational Session - When the pathway gets complex: Making thoughtful decisions across lines of therapy in RRMM- Sponsored by Menarini Stemline
Tracks
-
| Monday, April 20, 2026 |
| 5:40 PM - 6:25 PM |
| Room 4, Upper Level |
Details
Welcome and framing the landscape
The UK Pathway in 2026: Implications of early lenalidomide and anti-CD38 exposure
Mechanistic diversity and immune considerations in modern myeloma management
Panel discussion
Closing remarks
Speaker
Prof. Gordon Cook
Professor Of Haematology
University of Leeds
Speaker One
Professor of Haematology;
Clinical Director (Haematology), School of Medicine, University of Leeds, Leeds, UK
Prof. Karthik Ramasamy
Professor Of Haematology
Oxford University Hospitals NHS Foundation Trust
Speaker Two
Haematologist, Oxford University Hospitals NHS Trust, Oxford, UK
Joshua Richter
Mount Sinai
Speaker Three
Hematologist, Icahn School of Medicine at Mount Sinai, New York, USA
